HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

OTTAWA, March 03, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its financial results for the fiscal second quarter 2021, before market hours on March 18, 2021, as well as host a webcast for investors beginning at 8:30 a.m. EST.

HEXO Corp to Release Fiscal Second Quarter 2021 Financial Results and Host Investor Webcast

HEXO (HEXO) closed at $7.30 in the latest trading session, marking a -0.14% move from the prior day.

HEXO (HEXO) Stock Moves -0.14%: What You Should Know

The recent bullish sentiments over the cannabis market serve as a tailwind for HEXO stock as it looks to enter the U.S. market. The post Looking for a Strong Cannabis Play?

Looking for a Strong Cannabis Play? Hexo Is Your Best Bet

Aurora Cannabis

Aphria

OrganiGram Holdings Inc.

Tilray Brands

Institutional investors and hedge fund managers were "seeing green" in the fourth quarter.

5 Pot Stocks Money Managers Bought Hand Over Fist in Q4

Cronos Group

GameStop

SNDL Inc.

Canopy Growth

The bubble pop is moving quickly from sector to sector as marijuana stocks took center stage in one of the biggest and quickest to rise and fall recently. The post 7 Marijuana Stocks That Could Still Go Down in Flames appeared first on InvestorPlace.

7 Marijuana Stocks That Could Still Go Down in Flames

Curaleaf Holdings, Inc.

CRON stock stands to gain from state-level cannabis legalization as well as from speculation around federal legalization. The post Cronos Group and Other Cannabis Stocks Could See Higher Highs appeared first on InvestorPlace.

Cronos Group and Other Cannabis Stocks Could See Higher Highs

Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) (FRA:M5BQ) announced that cannabis products from well-known licensed producer HEXO Corp (TSE:HEXO) will be available to Canadian medical customers on Namaste subsidiary CannMart.com beginning in March on an ongoing basis, or until such time as the agreement is terminated by either party.   Namaste said the new agreement with HEXO points to the continued validation of CannMart.com as a platform for Canadian medical cannabis.

Namaste Technologies subsidiary CannMart inks Canadian supply deal with HEXO

Arena Pharmaceuticals

GW Pharmaceuticals

New Age Beverages

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

9 Red-Hot Cannabis Stocks Blazing This Week

Hexo makes an opportunistic purchase In the Canadian cannabis market. HEXO stock should benefit from the Zenabis Global acquisition by lowering its valuation through synergies.

Hexo Makes Opportunistic Purchase in Canadian Cannabis Market

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Canadian cannabis stocks have surged in 2021 and a few of them have exhibited irrational exuberance such as Tilray and Sundial. U.S. cannabis stocks continue to trade at a substantial discount despite possessing significantly stronger fundamentals.

Tilray, Sundial May Be In A Bubble But This Group Remains Attractive

Investors, it seems, are sobering up about the weed industry after pushing its stocks high over the past few days.

Why Marijuana Stocks Like Aurora Cannabis and HEXO Are Sinking Today

HEXO agrees to buy Zenabis Global in an all-stock deal of C$235 million. The company will now have a substantial scale adding 111,200 kg of cannabis production.

HEXO: Building A Formidable Canadian Cannabis Player

Arcturus Therapeutics

Chesapeake Energy

Fisker Inc

Ralph Lauren

Block

Under Armour

With the trading day more than halfway over, the broad markets were trading mixed.

Arcturus Therapeutics, Chesapeake Energy, Square, and More Wednesday Afternoon Analyst Calls

The odds of U.S. marijuana legalization may have improved, but investors should stay away from struggling pot play HEXO stock. The post After Last Week's Surge, Just Say No to Hexo appeared first on InvestorPlace.

After Last Week's Surge, Just Say No to Hexo

The marijuana producer is acquiring a key rival.

Why HEXO Stock Surged Today

The deal is the latest of several mergers and buyouts announced in the marijuana industry.

HEXO Acquiring Zenabis Global for $186 Million

Canadian cannabis company Hexo Corp. is acquiring Zenabis Global Inc. in an all-stock deal valued at about $235 million, in the latest tie-up in a sector that has been experiencing a burst of M&A activity.

Cannabis Watch: Hexo to buy Zenabis in latest tie-up in cannabis sector that's seeing a burst of M&A activity

GrowGeneration Corp

The shares of several cannabis companies are trading higher Tuesday as retail investor interest continues to drive the sector higher. The election of Joe Biden as U.S. President and recent Democratic Senate victories in Georgia have also lifted legalization sentiment.

Why Cannabis Stocks Are Trading Higher Today

OTTAWA and VANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. ("HEXO") (TSX: HEXO; NYSE: HEXO) and Zenabis Global Inc. ("Zenabis") (TSX: ZENA) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way of court-approved plan of arrangement under the Business Corporations Act (British Columbia), all of Zenabis' issued and outstanding common shares in an all-share transaction valued at approximately $235 million (the "Transaction"). Under the terms of the Arrangement Agreement, Zenabis shareholders will receive 0.01772 of a HEXO common share in exchange for each Zenabis common share held (the “Exchange Ratio”). The Exchange Ratio implies a premium per Zenabis common share of approximately 19% based on the 20-day volume-weighted average price ("VWAP") of Zenabis common shares on TSX and HEXO common shares on TSX as of February 12, 2021. Warrants and incentive securities of Zenabis will be adjusted in accordance with their terms to ultimately become exercisable to receive common shares of HEXO based on the share exchange ratio.

HEXO Corp. to acquire Zenabis Global Inc.

Greenlane Holdings

FSD Pharma

Innovative Industrial Properties

Akerna Corp

Village Farms International

Cannabis Stocks Felt the Reddit Rumble This Week

Volatility continues in cannabis stocks as quarterly earnings begin to filter in.

Why Aurora Cannabis, OrganiGram Holdings, and HEXO Dropped, Then Bounced Friday

HEXO stock could be a winner post-U.S. legalization. This is a stock with a head-start on cannabis-infused beverages, key to long-term growth.

Want to Play US Cannabis Legalization? Hexo Stock Is a Great Option

A political shift in the United States has unlocked an estimated $1.38 billion jackpot for struggling pot producers who have cashed in on a surge in their shares since President Joe Biden's election in November.

Once down in the weeds, cash-strapped pot producers raise billions in market rally

HEXO saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

HEXO Soars: Stock Adds 7.9% in Session

Analysts seem confused about whether Canopy's Q3 earnings were good or bad.

News for HEXO Corp Stock (HEXO)